FDA cleared expanded clinical applications for Inovedis’ SINEFIX Implant. Designed to replace traditional suture anchors for soft tissue-to-bone fixation, the device can now be used across a wider range of procedures, including:
SINEFIX is composed of a polyether ether ketone (PEEK) and includes one baseplate and two PEEK anchors, equipped with additional teeth to prevent tendon slippage. The innovative design addresses key limitations of traditional fixation methods.
“We are extremely happy to be able to meet the demand from surgeons to utilize SINEFIX in these extended indications,” said Lukas Floess, CEO and Co-founder. “Surgeons are no longer limited to using SINEFIX for small rotator cuff tears, and the prospects for its potential adoption in other areas of the body are considerable.”
FDA cleared expanded clinical applications for Inovedis' SINEFIX Implant. Designed to replace traditional suture anchors for soft tissue-to-bone fixation, the device can now be used across a wider range of procedures, including:
FDA cleared expanded clinical applications for Inovedis’ SINEFIX Implant. Designed to replace traditional suture anchors for soft tissue-to-bone fixation, the device can now be used across a wider range of procedures, including:
SINEFIX is composed of a polyether ether ketone (PEEK) and includes one baseplate and two PEEK anchors, equipped with additional teeth to prevent tendon slippage. The innovative design addresses key limitations of traditional fixation methods.
“We are extremely happy to be able to meet the demand from surgeons to utilize SINEFIX in these extended indications,” said Lukas Floess, CEO and Co-founder. “Surgeons are no longer limited to using SINEFIX for small rotator cuff tears, and the prospects for its potential adoption in other areas of the body are considerable.”
Copy to clipboard 
